Acasti Pharma Inc

Type: Company

Name: Acasti Pharma Inc

Nationality: Canada

Web Address: http://www.neptunebiotech.com/

First reported May 09 2013 - Updated May 09 2013 - 2 reports

Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal 2013 Results GlobeNewswire

(GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (NEPT) (NTB.TO) will be holding a conference call on Thursday, May 23 at 9:00 am ET to present its results for the fourth quarter and fiscal year ended February 28, 2013. The Company ... [Published Yahoo! Finance - May 09 2013]

Entities: Omega-3 Fatty Acid, Krill, Antarctic Krill, Acasti Pharma Inc

First reported May 06 2013 - Updated May 06 2013 - 1 reports

US International Trade Commission

Stockwatch: Neptune, Acasti complaint to be investig...

Neptune, Acasti complaint to be investigated by ITC2013-04-15 08:30 ET - News ReleaseMr. Henri Harland reportsTHE U.S. INTERNATIONAL TRADE COMMISSION (ITC) VOTES TO INSTITUTE PATENT INFRINGEMENTS INVESTIGATION BASED ON NEPTUNE & ACASTI COMPLAINTThe United ... [Published StockHouse USA - May 06 2013]

Entities: Aker BioMarine ASA, Patent, US International Trade Commission, Infringement

First reported Apr 24 2013 - Updated Apr 24 2013 - 1 reports

Acasti Pharma Inc

Form 6-K Acasti Pharma Inc. For: Apr 24

StreetInsider.com - Form 6-K Acasti Pharma Inc. For: Apr 24 ... [Published Street Insider - Apr 24 2013]

Entities: Acasti Pharma Inc

First reported Jan 07 2013 - Updated Jan 07 2013 - 1 reports

Acasti Pharma Shares to Trade on NASDAQ

Easily Send & Share Press ReleasesLAVAL, Quebec, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (Nasdaq:ACST) (TSX-V:APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, is pleased to announce that it has been approved ... [Published GlobeNewswire - Jan 07 2013]

Entities: Acasti Pharma Inc, Phospholipid, Omega-3 Fatty Acid, Stocks

Quotes

...filed by Aker that Neptune has not had the procedural opportunity to rebut," highlighted Benoit Huart, Director of Legal Affairs at Neptune. "We strongly believe that once this information is rebutted, the USPTO will be better placed to confirm our position."

Neptune Responds to Aker's Continued Attempts to Deflect Attention From Its Sustained Patent Infr ... [Published Zecco - May 15 2013]

...a clear and defined short-term timeline to conclude matters," said Henri Harland, president and chief executive officer of Neptune and Acasti. "Neptune and Acasti's IP is strong and valuable, and it is management's duty to defend it, not only for business ethical reasons, but mainly because it is a fundamental asset and an important part of our shareholder value as it pertains to both our neutraceutical and pharmaceutical businesses" added Mr. Harland

Stockwatch: Neptune, Acasti complaint to be investig... [Published StockHouse USA - May 06 2013]

Benoit Huart, General Counsel of Neptune, stated that "the status of this patent has practically no impact on our business: it concerns flavonoids, not phospholipids. Whenever we have pursued patent protection covering phospholipids, such as in the U S , Australia, and Canada, we did not base it on flavonoids and we have succeeded with the issuance and allowance of patents in those jurisdictions. This opposition has also given us an opportunity to gather strategic information, which will be useful as we continue to execute our international patent strategy."

Neptune Provides Update on European Patent Dispute and Maintains Its International Patent Strategy [Published Automotive Technology - Apr 29 2013]

...company is a subsidiary of the fund, a nonprofit corporation with 20 member villages along the west coast of Alaska from Scammon Bay to Platinum. "But the best thing we are doing is providing hundreds of jobs right in our region OTTAWA - The public warning issued earlier today has been expanded to include additional products and codes."

IN BRIEF - Alaska fish processors get big pay increase [Published Fish Information & Services - Apr 15 2013]

More Content

sort by: Date \| Relevance
Neptune Responds to Aker's Continued Attempts t... [Published Zecco - May 15 2013]
Neptune to Hold Conference Call [Published Noodls - May 09 2013]
Neptune to Hold Conference Call to Discuss Four... [Published Yahoo! Finance - May 09 2013]
Neptune to Hold Conference Call to Discuss Four... [Published Individual.com - May 09 2013]
Stockwatch: Neptune, Acasti complaint to be inv... [Published StockHouse USA - May 06 2013]
Neptune Provides Update on European Patent Disp... [Published Automotive Technology - Apr 29 2013]
Form 6-K Acasti Pharma Inc. For: Apr 24 [Published Street Insider - Apr 24 2013]
IN BRIEF - Alaska fish processors get big pay i... [Published Fish Information & Services - Apr 15 2013]
The U.S. International Trade Commission (ITC) V... [Published Interest!ALERT - Apr 15 2013]
IN BRIEF - Polar Seafood prepared for Greenland... [Published Fish Information & Services - Apr 15 2013]
IN BRIEF - Codfarmers: Update on voluntary debt... [Published Fish Information & Services - Apr 15 2013]
IN BRIEF - Pescanova sells Ecuador shrimp farms [Published Fish Information & Services - Apr 15 2013]
The U.S. International Trade Commission (ITC) V... [Published Yahoo! Finance - Apr 15 2013]
The U.S. International Trade Commission (ITC) V... [Published GlobeNewswire: Acquisitions News - Apr 15 2013]
The U.S. International Trade Commission (ITC) V... [Published Individual.com - Apr 15 2013]
Acasti's NKLP66 data show 23% triglyceride redu... [Published Stockwatch - Mar 19 2013]
Acasti Pharma Presents Preliminary Data Moving ... [Published GlobeNewswire: Acquisitions News - Mar 19 2013]
Acasti Pharma Reports Its Third Quarter Results [Published GlobeNewswire: Acquisitions News - Jan 15 2013]
Acasti Pharma Shares to Trade on NASDAQ [Published GlobeNewswire - Jan 07 2013]
Acasti Pharma Provides an Insight of Its Curren... [Published GlobeNewswire: Acquisitions News - Dec 17 2012]
IIROC: Resume, ACASTI PHARMA INC [Published Marketwire - Breaking News Releases - Dec 04 2012]
Neptune Announces Royalty Prepayment Agreement ... [Published GlobeNewswire: Acquisitions News - Dec 04 2012]
Acasti Pharma Becomes Royalty Free [Published GlobeNewswire: Acquisitions News - Dec 04 2012]
IIROC: Halt, Acasti Pharma Inc. [Published Marketwire - Breaking News Releases - Dec 04 2012]
Acasti Pharma Reports Its Second Quarter Results [Published GlobeNewswire - Oct 17 2012]
Neptune Files a Second Patent Infringement Suit... [Published GlobeNewswire - Oct 02 2012]

Press Releases

sort by: Date \| Relevance
The U.S. International Trade Commission (ITC) V... [Published GlobeNewswire: Acquisitions News - Apr 15 2013]
Acasti Pharma Presents Preliminary Data Moving ... [Published GlobeNewswire: Acquisitions News - Mar 19 2013]
Acasti Pharma Reports Its Third Quarter Results [Published GlobeNewswire: Acquisitions News - Jan 15 2013]
Acasti Pharma Provides an Insight of Its Curren... [Published GlobeNewswire: Acquisitions News - Dec 17 2012]
IIROC: Resume, ACASTI PHARMA INC [Published Marketwire - Breaking News Releases - Dec 04 2012]